⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9899793 | 0.83 | — | — | |
| SCHEMBL3114602 | 0.72 | — | — | |
| SCHEMBL5390716 | 0.61 | — | — | |
| SCHEMBL14315764 | 0.57 | CRBN (0.42) | — | |
| SCHEMBL5894794 | 0.56 | — | — | |
| SCHEMBL4751281 | 0.56 | — | — | |
| SCHEMBL2920862 | 0.56 | — | — | |
| SCHEMBL8874187 | 0.55 | — | — | |
| SCHEMBL828805 | 0.53 | — | — | |
| SCHEMBL7211064 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4103278-A1 | SMALL MOLECULE STING ANTAGONISTS | Curadev Pharma Pvt. Ltd. (IN) | 2022-12-21 | — | — | EP | claimed |
| CN-114401969-A | Heterocyclic compounds | 豪夫迈·罗氏有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-104370853-B | GSK-3 beta inhibitor or its salt and medicinal usage thereof | 复旦大学 | 2016-08-10 | — | — | CN | claimed |
| CN-104370853-A | GSK-3beta inhibitor or its salt and medicine application thereof | UNIV FUDAN | 2015-02-25 | — | — | CN | claimed |
| CN-101365696-A | Compounds and compositions as modulators of steroid hormone nuclear receptors | IRM LLC (BM) | 2009-02-11 | — | — | CN | claimed |
| CN-1635891-A | Tetrahydroquinoline analogues as muscarinic agonists | ACADIA PHARM INC (US) | 2005-07-06 | — | — | CN | claimed |
| EP-1537123-A1 | COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2005-06-08 | — | — | EP | claimed |
| WO-2004002992-A1 | COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-01-08 | — | — | WO | claimed |
| US-12006289-B2 | Potassium channel inhibitors | SANIONA A/S (DK) | 2024-06-11 | — | — | US | disclosed |
| CN-113631538-B | Novel potassium channel inhibitors | 萨尼奥纳有限责任公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-110494555-B | Generation of lung bud organoids with branched structures and use thereof for modeling lung disease | 纽约市哥伦比亚大学理事会 | 2024-04-02 | — | — | CN | disclosed |
| WO-2024050513-A1 | PHENOTHIAZINES FOR TREATING MITOCHONDRIAL DISEASE | ACUREX BIOSCIENCES CORPORATION (US) | 2024-03-07 | — | — | WO | disclosed |
| US-20240034717-A1 | NOVEL POTASSIUM CHANNEL INHIBITORS | SANIONA A/S (DK) | 2024-02-01 | — | — | US | disclosed |
| CN-112218862-B | Oxazolidinone antibiotic compounds and process for preparing same | 巴格沃克斯研究有限公司 | 2024-01-02 | — | — | CN | disclosed |
| EP-0149297-A1 | Process for preparing 3H-Phenothlazin-3-ones | MERCK FROSST CANADA INC. (CA) | 1985-07-24 | — | — | EP | disclosed |
| EP-0047164-B1 | PROCESS FOR PREPARING 3-CHLORO-6-(2-HYDROXYPHENYL)-PYRIDAZINES | SMITHKLINE BECKMAN CORPORATION (US) | 1985-03-27 | — | — | EP | disclosed |
| US-4340733-A | Process for preparing 3-chloro-6-(2-hydroxyphenyl)-pyridazines | SMITHKLINE CORPORATION (US) | 1982-07-20 | — | — | US | disclosed |
| EP-0047164-A2 | Process for preparing 3-chloro-6-(2-hydroxyphenyl)-pyridazines | SMITHKLINE BECKMAN CORPORATION (US) | 1982-03-10 | — | — | EP | disclosed |
| US-4259498-A | Process for preparing benzisothiazole-1,1-dioxide and naphtho-1,2-thiazine-1,1-dioxide compounds | POLAROID CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
| US-4191689-A | Benzisothiazole-1,1-dioxide and naphtho-1,2-thiazine-1,1-dioxide compounds | POLAROID CORPORATION (US) | 1980-03-04 | — | — | US | disclosed |